Search

Our results identify a pretreatment tumor microenvironment that predicts response to immune checkpoint blockade, which can be therapeutically attained

In this study, we investigate the in vivo synergy between romidepsin and cytarabine

These findings suggest that tumor cells employ multiple epigenetic and genetic mechanisms to evade immune control

We found two known risk factors in a large cohort of children treated for ALL and identified other factors associated with venous thromboembolism

This systematic review shows that children treated with platinum analogues are at risk of developing hearing loss

In this review, we discuss the different subsets of tumor-infiltrating dendritic cells and their role in anti-tumor immunity

The ANZCHOG-BN is a new biobank network in Australasia that was developed to improve and streamline access to high-quality pediatric and AYA cancer biospecimens

Our findings shed light on the mechanisms of leukemia-induced bone loss

Rishi S. Kotecha MB ChB (Hons) MRCPCH FRACP PhD Co-Head, Leukaemia Translational Research rishi.kotecha@health.wa.gov.au Co-Head, Leukaemia

Four The Kids Research Institute Australia researchers are among those who have received funding in the WA State Government's Merit Award Program announced today.